Osaic Holdings
IDNA icon

Osaic Holdings’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Osaic Holdings’s Portfolio IDNA Stock Details IDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$324K Buy
11,158
+2,438
+28% +$70.8K ﹤0.01% 3753
2025
Q4 		$228K Buy
8,720
+914
+12% +$23.5K ﹤0.01% 4033
2025
Q3 		$182K Sell
7,806
-801
-9% -$17.7K ﹤0.01% 4296
2025
Q2 		$177K Sell
8,607
-3,057
-26% -$61.6K ﹤0.01% 4047
2025
Q1 		$239K Sell
11,664
-13,636
-54% -$304K ﹤0.01% 3485
2024
Q4 		$573K Sell
25,300
-1,423
-5% -$34.2K ﹤0.01% 2667
2024
Q3 		$658K Sell
26,723
-807
-3% -$19.7K ﹤0.01% 2618
2024
Q2 		$636K Sell
27,530
-38,170
-58% -$894K ﹤0.01% 2563
2024
Q1 		$1.58M Buy
65,700
+16,744
+34% +$392K ﹤0.01% 1879
2023
Q4 		$1.13M Buy
48,956
+3,629
+8% +$72.9K ﹤0.01% 2397
2023
Q3 		$922K Sell
45,327
-917
-2% -$20.6K ﹤0.01% 2700
2023
Q2 		$1.08M Buy
46,244
+176
+0.4% +$4.22K ﹤0.01% 2447
2023
Q1 		$1.07M Buy
46,068
+7,234
+19% +$181K ﹤0.01% 2384
2022
Q4 		$977K Buy
38,834
+21,428
+123% +$576K ﹤0.01% 2388
2022
Q3 		$459K Buy
17,406
+5,829
+50% +$180K ﹤0.01% 2978
2022
Q2 		$339K Buy
11,577
+531
+5% +$15.8K ﹤0.01% 3318
2022
Q1 		$186K Buy
11,046
+479
+5% +$16.9K ﹤0.01% 4090
2021
Q4 		$463K Buy
10,567
+685
+7% +$32.4K ﹤0.01% 3141
2021
Q3 		$495K Sell
9,882
-114
-1% -$5.94K ﹤0.01% 3043
2021
Q2 		$523K Buy
9,996
+421
+4% +$19.8K ﹤0.01% 2991
2021
Q1 		$439K Buy
9,575
+6,250
+188% +$305K ﹤0.01% 3011
2020
Q4 		$153K Buy
3,325
+76
+2% +$3.28K ﹤0.01% 3722
2020
Q3 		$127K Buy
3,249
+1,325
+69% +$50.9K ﹤0.01% 3620
2020
Q2 		$73K Buy
+1,924
New +$64.9K ﹤0.01% 3914

Other funds holding IDNA

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CCA
Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return

Osaic Holdings's IDNA Position: Q1 2026 in Review

Osaic Holdings increased its iShares Genomics Immunology and Healthcare ETF (IDNA) stake by 28% in Q1 2026, buying an estimated $70.8K and bringing the position to 11,158 shares worth $324K. The position accounts for ﹤0.01% of the portfolio, ranked #3753.

Osaic Holdings first reported a position in IDNA in Q2 2020 and has held it in 24 quarters since. The position peaked at $1.58M in Q1 2024. 60 funds tracked by Wall St. Rank hold IDNA as of Q1 2026.

  • Osaic Holdings held 11,158 shares of iShares Genomics Immunology and Healthcare ETF worth $324K as of Q1 2026.
  • Osaic Holdings bought 2,438 iShares Genomics Immunology and Healthcare ETF shares in Q1 2026, an estimated $70.8K.
  • iShares Genomics Immunology and Healthcare ETF made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #3753 holding.
  • Osaic Holdings first reported a position in iShares Genomics Immunology and Healthcare ETF in Q2 2020 and has held it in 24 quarters since.
  • Osaic Holdings's iShares Genomics Immunology and Healthcare ETF position peaked at $1.58M in Q1 2024.
  • 60 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.